PharmiNews

Directory of Pharma Companies and News

Company Profile

Themis Bioscience GmbH

Themis Bioscience GmbH logo
Category
Themis Bioscience GmbH develops prophylactic vaccines from the preclinical to the early clinical phase, focusing on emerging tropical infectious diseases, with initial vaccine candidates currently being developed against Chikungunya and Zika. The company's highly innovative and fully patent-protected measles virus vaccine vector technology platform forms the basis for all current vaccine candidates of the Vienna-based company.
Keywords:
0 results
Brought to you by PharmiWeb.com - Latest Jobs in Pharma